Deutsche Bank upgraded shares of Koninklijke DSM (OTCMKTS:RDSMY) from a hold rating to a buy rating in a report released on Friday morning, The Fly reports.

A number of other research analysts have also recently commented on RDSMY. Zacks Investment Research cut shares of Koninklijke DSM from a buy rating to a hold rating in a report on Tuesday, September 19th. assumed coverage on shares of Koninklijke DSM in a report on Friday, September 1st. They issued a buy rating on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of Hold and an average price target of $24.00.

Koninklijke DSM (OTCMKTS:RDSMY) opened at $23.41 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.11 and a debt-to-equity ratio of 0.44. Koninklijke DSM has a 1-year low of $14.50 and a 1-year high of $23.50.

TRADEMARK VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/05/koninklijke-dsm-rdsmy-rating-increased-to-buy-at-deutsche-bank.html.

Koninklijke DSM Company Profile

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.

The Fly

Receive News & Stock Ratings for Koninklijke DSM NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM NV and related stocks with our FREE daily email newsletter.